Androgen/androgen receptor axis maintains and promotes cancer cell stemness through direct activation of Nanog transcription in hepatocellular carcinoma.

Regulation of p53wt glioma cell proliferation by androgen receptor-mediated inhibition of small VCP/p97-interacting protein expression. Oncotarget (2017) 0.75

Gender disparity in liver cancer due to sex differences in MyD88-dependent IL-6 production. Science (2007) 12.91

Nanog is the gateway to the pluripotent ground state. Cell (2009) 7.27

A hierarchical network of transcription factors governs androgen receptor-dependent prostate cancer growth. Mol Cell (2007) 5.99

Molecular biology of the androgen receptor. J Clin Oncol (2002) 5.08

Cancer stem cells: current status and evolving complexities. Cell Stem Cell (2012) 5.07

Intratumoral de novo steroid synthesis activates androgen receptor in castration-resistant prostate cancer and is upregulated by treatment with CYP17A1 inhibitors. Cancer Res (2011) 2.81

Functional evidence that the self-renewal gene NANOG regulates human tumor development. Stem Cells (2009) 2.59

Androgen receptor is a new potential therapeutic target for the treatment of hepatocellular carcinoma. Gastroenterology (2008) 2.36

Androgen-induced differentiation and tumorigenicity of human prostate epithelial cells. Cancer Res (2004) 2.32

Foxa1 and Foxa2 are essential for sexual dimorphism in liver cancer. Cell (2012) 2.05

ASC-J9 ameliorates spinal and bulbar muscular atrophy phenotype via degradation of androgen receptor. Nat Med (2007) 1.87

Gender disparity of hepatocellular carcinoma: the roles of sex hormones. Oncology (2010) 1.68

Nanog regulates self-renewal of cancer stem cells through the insulin-like growth factor pathway in human hepatocellular carcinoma. Hepatology (2012) 1.61

Emerging mechanisms of resistance to androgen receptor inhibitors in prostate cancer. Nat Rev Cancer (2015) 1.55

Cell cycle-related kinase mediates viral-host signalling to promote hepatitis B virus-associated hepatocarcinogenesis. Gut (2014) 1.47

Diverse roles of androgen receptor (AR) domains in AR-mediated signaling. Nucl Recept Signal (2008) 1.47

Selective DNA recognition by the androgen receptor as a mechanism for hormone-specific regulation of gene expression. Mol Genet Metab (2003) 1.37

Role of sex steroid receptors in pathobiology of hepatocellular carcinoma. World J Gastroenterol (2008) 1.33

Differential androgen deprivation therapies with anti-androgens casodex/bicalutamide or MDV3100/Enzalutamide versus anti-androgen receptor ASC-J9(R) Lead to promotion versus suppression of prostate cancer metastasis. J Biol Chem (2013) 1.23

New therapeutic approach to suppress castration-resistant prostate cancer using ASC-J9 via targeting androgen receptor in selective prostate cells. Am J Pathol (2012) 1.08

New therapy targeting differential androgen receptor signaling in prostate cancer stem/progenitor vs. non-stem/progenitor cells. J Mol Cell Biol (2012) 1.07

Evaluation of antiandrogen therapy in unresectable hepatocellular carcinoma: results of a European Organization for Research and Treatment of Cancer multicentric double-blind trial. J Clin Oncol (1998) 1.02

Cell-autonomous intracellular androgen receptor signaling drives the growth of human prostate cancer initiating cells. Prostate (2010) 1.01

Phase II study of flutamide in the treatment of hepatocellular carcinoma. Cancer (1996) 1.01

Emerging role of nanog in tumorigenesis and cancer stem cells. Int J Cancer (2014) 0.96

Androgen receptor roles in hepatocellular carcinoma, fatty liver, cirrhosis and hepatitis. Endocr Relat Cancer (2014) 0.95

Expression of androgen and estrogen signaling components and stem cell markers to predict cancer progression and cancer-specific survival in patients with metastatic prostate cancer. Clin Cancer Res (2014) 0.95

Agonist and antagonist switch DNA motifs recognized by human androgen receptor in prostate cancer. EMBO J (2014) 0.92

Arachidonic acid activation of intratumoral steroid synthesis during prostate cancer progression to castration resistance. Prostate (2010) 0.91

Adaptive responses of androgen receptor signaling in castration-resistant prostate cancer. Oncotarget (2015) 0.87

Androgen receptor signaling in hepatocellular carcinoma and pancreatic cancers. World J Gastroenterol (2014) 0.86

Suppression of androgen receptor enhances the self-renewal of mesenchymal stem cells through elevated expression of EGFR. Biochim Biophys Acta (2013) 0.86

Expression of androgen receptor splice variants in clinical breast cancers. Oncotarget (2015) 0.85

Determinants of Receptor- and Tissue-Specific Actions in Androgen Signaling. Endocr Rev (2015) 0.84

Concise review: androgen receptor differential roles in stem/progenitor cells including prostate, embryonic, stromal, and hematopoietic lineages. Stem Cells (2014) 0.83

The pluripotency factor Nanog is directly upregulated by the androgen receptor in prostate cancer cells. Prostate (2014) 0.83

Human haematopoietic stem/progenitor cells express several functional sex hormone receptors. J Cell Mol Med (2015) 0.82

Development and exploitation of a novel mutant androgen receptor modelling strategy to identify new targets for advanced prostate cancer therapy. Oncotarget (2015) 0.82

Androgen receptor and prostate cancer stem cells: biological mechanisms and clinical implications. Endocr Relat Cancer (2015) 0.81

Pin1-Nanog expression in human glioma is correlated with advanced tumor progression. Oncol Rep (2013) 0.80

Novel roles of androgen receptor, epidermal growth factor receptor, TP53, regulatory RNAs, NF-kappa-B, chromosomal translocations, neutrophil associated gelatinase, and matrix metalloproteinase-9 in prostate cancer and prostate cancer stem cells. Adv Biol Regul (2015) 0.80

Regulation of tumor cell plasticity by the androgen receptor in prostate cancer. Endocr Relat Cancer (2015) 0.79

Androgen receptor in hepatocarcinogenesis: Recent developments and perspectives. Oncol Lett (2015) 0.79

Sorafenib Action in Hepatitis B Virus X-Activated Oncogenic Androgen Pathway in Liver through SHP-1. J Natl Cancer Inst (2015) 0.77

Transcription-replication collision increases recombination efficiency between plasmids. Plasmid (2013) 0.76

MicroRNA-122 sensitizes HCC cancer cells to adriamycin and vincristine through modulating expression of MDR and inducing cell cycle arrest. Cancer Lett (2011) 1.34

IGF/STAT3/NANOG/Slug Signaling Axis Simultaneously Controls Epithelial-Mesenchymal Transition and Stemness Maintenance in Colorectal Cancer. Stem Cells (2016) 0.89

Circulating tumor DNA: a promising biomarker in the liquid biopsy of cancer. Oncotarget (2016) 0.85

Targeted next-generation sequencing identification of mutations in patients with disorders of sex development. BMC Med Genet (2016) 0.84

MicroRNA-122 confers sorafenib resistance to hepatocellular carcinoma cells by targeting IGF-1R to regulate RAS/RAF/ERK signaling pathways. Cancer Lett (2015) 0.83

Sox9 regulates self-renewal and tumorigenicity by promoting symmetrical cell division of cancer stem cells in hepatocellular carcinoma. Hepatology (2016) 0.81

Positive lymph node metastasis has a marked impact on the long-term survival of patients with hepatocellular carcinoma with extrahepatic metastasis. PLoS One (2014) 0.80

MEF2D Transduces Microenvironment Stimuli to ZEB1 to Promote Epithelial-Mesenchymal Transition and Metastasis in Colorectal Cancer. Cancer Res (2016) 0.78

SIRT1-mediated transcriptional regulation of SOX2 is important for self-renewal of liver cancer stem cells. Hepatology (2016) 0.75

Myocyte enhancer factor 2D promotes colorectal cancer angiogenesis downstream of hypoxia-inducible factor 1α. Cancer Lett (2017) 0.75